# Long‐Term Trends in Parkinson's Disease and Associated Mental Health Disorders: Insights From the CDC WONDER Database, 1999–2023

**Authors:** Taha Alam, Waqas Burney, Sohaima Kamal, Ahmad Kamal, Iman Osman Abufatima, Umair Ali, Muhammad Mukhlis, Aneezeh Khatri, Norina Usman, Noorulain Aqeel, Mohammed Shahabuddin Mollah, Muhammad Shaheer Bin Faheem

PMC · DOI: 10.1002/brb3.71190 · Brain and Behavior · 2026-01-13

## TL;DR

Parkinson's disease and related mental health disorders caused a rising number of deaths in the U.S. from 1999 to 2023, with higher rates in males, older adults, and nonmetropolitan areas.

## Contribution

This study provides the first comprehensive analysis of mortality trends for Parkinson's and comorbid mental health disorders in the U.S. over 24 years.

## Key findings

- Age-adjusted mortality rates for Parkinson's disease increased from 3.83 to 8.49 per 100,000 between 1999 and 2023.
- Males had consistently higher mortality rates than females, and non-Hispanic Whites had the highest rates.
- Nursing and long-term care facilities accounted for over half of all recorded deaths.

## Abstract

The U.S. population is aging with an increasing burden of Parkinson's disease (PD) and its frequent co‐occurring mental health disorders. However, mortality trends related to PD and these comorbid mental health disorders among older adults remain understudied.

To examine trends in mortality due to PD and related mental health conditions among adults aged 45 and older in the United States from 1999 to 2023.

We extracted mortality data for PD and mental health‐related conditions among individuals aged 45 and older from the CDC WONDER database. Age‐adjusted mortality rates (AAMRs) were calculated per 100,000 persons and stratified by sex, race/ethnicity, census region, and urbanization status. Annual percentage changes (APCs) with their 95% confidence intervals (CIs) were estimated using the Joinpoint regression program.

PD and its associated mental health disorders resulted in 238,378 deaths between 1999 and 2023. The AAMR increased significantly from 3.83 in 1999 to 8.49 in 2023 with an AAPC of 3.20 (p = 0.005). Males consistently showed higher AAMRs than females (overall AAMR male: 11.40 vs. female: 5.75). Non‐Hispanic (NH) Whites had the highest mortality rates (8.67), while NH African Americans exhibited the lowest (4.66). Crude mortality rate was the highest among older adults (21.09), reflecting the greatest burden in this population. Similarly, the mortality rates were higher in nonmetropolitan areas (8.15) than the metropolitan areas (7.72). The highest AAMR was noted in the Midwest (9.18), with a standard deviation of 14.08 in Minnesota and 5.44 in Arizona. The majority of the deaths were recorded in nursing or long‐term care facilities (52.65%).

The increasing trend in mortality highlights the necessity of focused preventive, diagnostic, and treatment approaches for all susceptible groups.

## Linked entities

- **Diseases:** Parkinson's disease (MONDO:0005180)

## Full-text entities

- **Genes:** APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324] {aka BTPS2, DESMD, DP2, DP2.5, DP3, GS}
- **Diseases:** tremor (MESH:D014202), AAMR (OMIM:615510), fatalities (MESH:C565541), mood disorders (MESH:D019964), mental (MESH:D008607), PD (MESH:D010300), anxiety (MESH:D001007), Depression (MESH:D003866), chronic illness (MESH:D002908), psychosis (MESH:D011618), disease (MESH:D004194), anxiety disorders (MESH:D001008), cognitive and behavioral complications (MESH:D000079690), AAMRs (MESH:D003643), cognitive disorders (MESH:D003072), neuropsychiatric complications (MESH:D008107), WONDER (MESH:D014947), institutional dependency (MESH:D019966), hallucinations (MESH:D006212), Cancer (MESH:D009369), movement-disorder (MESH:D009069), dementia (MESH:D003704), motor disorder (MESH:D000068079), developmental disorders (MESH:D002658), neurologic disease (MESH:D020271), neuropsychiatric side effects (MESH:D064420), ICD-10-CM (OMIM:252500), neuropsychiatric (MESH:C000631768), bradykinesia (MESH:D018476), rigidity (MESH:D009127), delusions (MESH:D063726), Mental Health Disorders (OMIM:603663), mental and behavioral disorder (MESH:D001523), personality disorders (MESH:D010554), neurodegeneration (MESH:D019636)
- **Chemicals:** dopaminergic (MESH:D004298)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12796856/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12796856/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC12796856/full.md

---
Source: https://tomesphere.com/paper/PMC12796856